Abstract
Acute bacterial prostatitis is a common and clinically important genitourinary disorder. Patient populations who are at especially high risk of acute prostatitis include those with diabetes, cirrhosis, and suppressed immune systems. The cause is usually an ascending infection, but bacteria can also be introduced during transrectal prostate biopsy. Clinical presentation ranges from mild lower urinary tract symptoms to full sepsis. The causative organisms are usually similar to those that cause other common genitourinary infections, and include Escherichia coli and Enterococcus spp. Oral or intravenous antibiotics are usually effective for curing the infection and progression to chronic bacterial prostatitis is, therefore, uncommon. Immunosuppressed patients require special consideration, as bacterial prostatitis in these patients can be caused by atypical infecting organisms and might, therefore, require additional therapies. A lack of response to standard therapy can lead to complications such as a prostatic abscess or fistula.
Key Points
-
Acute bacterial prostatitis is most commonly caused by an ascending urinary tract infection, and patients can present with a range of symptoms from local to systemic
-
Causative organisms are usually E. coli and Enterococcus spp.; however, rare organisms can be isolated, especially from immunocompromised hosts
-
Clinical evaluation includes a full history and physical examination, urinalysis and urine culture, as well as a CBC and blood cultures if systemic infection is suspected
-
Local, mild cases are treated with 2–4 weeks of oral antibiotics, preferably a fluoroquinolone, whereas severe cases can require hospitalization and intravenous antibiotic therapy
-
Transrectal ultrasonography can assist in the diagnosis of prostatic abscess, which is treated with minimally invasive or surgical drainage
-
As resistant bacteria become more prevalent, the frequency of acute prostatitis following transrectal prostate biopsy is increasing
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Collins, M. M. et al. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J. Urol. 167, 1363–1366 (2002).
Pontari, M. A., Joyce, G. F., Wise, M. & McNaughton-Collins, M. Prostatitis. J. Urol. 177, 2050–2057 (2007).
Bartoletti, R., Mondaini, N., Pavone, C., Dinelli, N. & Prezioso D. Introduction to chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS). Arch. Ital. Urol. Androl. 79, 55–57 (2007).
Krieger, J. N., Nyberg, L. Jr & Nickel, J. C. NIH consensus definition and classification of prostatitis. JAMA 282, 236–237 (1999).
Roberts, R. O. et al. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of urinary symptoms and health status among men. Urology 51, 578–584 (1998).
Rhee, J. J., Piesman, M., Costabile, R. A. & Gillenwater, J. Y. Acute bacterial prostatitis and prostatic abscess. eMedicine [online], (2011).
Wyndaele, J. J. Complications of intermittent catheterization: their prevention and treatment. Spinal Cord 40, 536–541 (2002).
Dulabon, L. M., LaSpina, M., Riddell, S. W., Kiska, D. L. & Cynamon, M. Pseudomonas aeruginosa acute prostatitis and urosepsis after sexual relations in a hot tub. J. Clin. Microbiol. 47, 1607–1608 (2009).
Etienne, M. et al. Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis. BMC Infect. Dis. 8, 12 (2008).
Millán-Rodríguez, F. et al. Acute bacterial prostatitis: two different subcategories according to a previous manipulation of the lower urinary tract. World J. Urol. 24, 45–50 (2006).
Kulchavenya, E. & Khomyakov, V. Male genital tuberculosis in Siberians. World J. Urol. 24, 74–78 (2006).
Aust, T. R. & Massey, J. A. Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guérin immunotherapy. Int. J. Urol. 12, 920–921 (2005).
Sreejith, P. et al. Allograft and prostatic involvement in a renal transplant recipient with disseminated tuberculosis. Indian J. Nephrol. 20, 40–42 (2010).
Johnson, J. R. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4, 80–128 (1991).
Soto, S. M. et al. Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J. Urol. 177, 365–368 (2007).
Kanamaru, S. et al. Increased biofilm formation in Escherichia coli isolated from acute prostatitis. Int. J. Antimicrob. Agents 28 (Suppl. 1), S21–S25 (2006).
Costerton, J. W., Lewandowski, Z., Caldurell, D. E., Korber, D. R. & Lappin-Scott, H. M. Microbial biofilms. Annu. Rev. Microbiol. 49, 711 (1995).
Cornia, P. B., Takahashi, T. A. & Lipsky, B. A. The microbiology of bacteriuria in men: a 5-year study at a Veterans' Affairs hospital. Diagn. Microbiol. Infect. Dis. 56, 25–30 (2006).
Gamé, X. et al. Total and free serum prostate specific antigen levels during the first month of acute prostatitis. Eur. Urol. 43, 702–705 (2003).
Horcajada, J. P. et al. Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications. Scand. J. Infect. Dis. 35, 114–120 (2003).
Ulleryd, P., Zackrisson, B., Aus, G., Bergdahl, S. & Hugosson, J., Sandberg, T. Selective urological evaluation in men with febrile urinary tract infection. BJU Int. 88, 15–20 (2001).
Mateos, J. J. et al. 111Indium-labeled leukocyte scintigraphy in the detection of acute prostatitis. Nucl. Med. Commun. 23, 1137–1142 (2002).
Etienne, M. et al. Should blood cultures be performed for patients with acute prostatitis? J. Clin. Microbiol. 48, 1935–1938 (2010).
Naber, K. G. & Sörgel, F. Antibiotic therapy—rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue. Andrologia 35, 331–335 (2003).
Grabe, M. et al. Guidelines on urological infections. European Association of Urology [online], (2011).
Goto, T. et al. Diffusion of piperacillin, cefotiam, minocycline, amikacin and ofloxacin into the prostate. Int. J. Urol. 5, 243–246 (1998).
Neal, D. E. Treatment of acute prostatitis. In Textbook of Prostatitis (ed. Nickel, J. C.) 279–284 (Isis Medical Media, Oxford, 1999).
Ulleryd, P. & Sandberg, T. Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up. Scand. J. Infect. Dis. 35, 34–39 (2003).
Wagenlehner, F. M. & Naber, K. G. Therapy of prostatitis syndrome. Urologe A. 40, 24–28 (2001).
Schaeffer, A. J. et al. Summary consensus statement: diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome. Eur. Urol. 43 (Suppl. 2), 1–4 (2003).
Schaeffer, A. J. Prostatitis: US perspective. Int. J. Antimicrob. Agents 11, 205–211 (1999).
Nickel, J. C. Alpha-blockers for the treatment of prostatitis-like syndromes. Rev. Urol. 8 (Suppl. 4), S26–S34 (2006).
Soliman, M. S., Lessnau, K. D. & Hashmat, A. Tuberculosis of the genitourinary system: treatment & medication. eMedicine [online], (2011).
Cek, M. et al. EAU Guidelines for the management of genitourinary tuberculosis. Eur. Urol. 48, 353–362 (2005).
Benson, P. J. & Smith, C. S. Cytomegalovirus prostatitis. Urology 40, 165–167 (1992).
Hood, S. V. et al. Prostatitis and epididymo-orchitis due to Aspergillus fumigatus in a patient with AIDS. Clin. Infect. Dis. 26, 229–231 (1998).
Adams, J. R. et al. Acquired immune deficiency syndrome manifesting as prostate nodule secondary to cryptococcal infection. Urology 39, 289–291 (1992).
Marans, H. Y. et al. Prostatic abscess due to Histoplasma capsulatum in the acquired immune deficiency syndrome. J. Urol. 145, 1275–1276 (1991).
Leport, C. et al. Bacterial prostatitis in patients infected with the human immunodeficiency virus. J. Urol. 141, 334–336 (1989).
Benway, B. M. & Moon, T. D. Bacterial prostatitis. Urol. Clin. North Am. 35, 23–32 (2008).
Trauzzi, S. J., Kay, C. J., Kaufman, D. G. & Lowe, F. C. Management of prostatic abscess in patients with human immunodeficiency syndrome. Urology 43, 629–633 (1994).
Benson, P. J. & Smith, C. S. Cytomegalovirus prostatitis. Urology 40, 165–167 (1992).
McKay, T. C., Albala, D. M., Sendelbach, K. & Gattuso, P. Cytomegalovirus prostatitis. Case report and review of the literature. Int. Urol. Nephrol. 26, 535–540 (1994).
Yoon, G. S., Nagar, M. S., Tavora, F. & Epstein, J. I. Cytomegalovirus prostatitis: a series of 4 cases. Int. J. Surg. Pathol. 18, 55–59 (2010).
Miura, T. et al. Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature. Int. J. Urol. 15, 457–459 (2008).
Ozden, E. et al. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Urology 74, 119–123 (2009).
Shigehara, K., Miyagi, T., Nakashima, T. & Shimamura, M. Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis. J. Infect. Chemother. 14, 40–43 (2008).
Stoica, G. et al. Epidemiology and treatment of acute prostatitis after prostatic biopsy. Prog. Urol. 17, 960–963 (2007).
Kanjanawongdeengam, P., Viseshsindh, W., Santanirand, P., Prathombutr, P. & Nilkulwattana, S. Reduction in bacteremia rates after rectum sterilization before transrectal, ultrasound-guided prostate biopsy: a randomized controlled trial. J. Med. Assoc. Thai. 92, 1621–1626 (2009).
Aravantinos, E. et al. Ultrasound-guided transrectal placement of a drainage tube as therapeutic management of patients with prostatic abscess. J. Endourol. 22, 1751–1754 (2008).
Rabii, R., Rais, H., Joual, A., el Mrini, M. & Benjelloun, S. Prostatic abscesses. A review. Ann. Urol. (Paris) 33, 271–273 (1999).
Barozzi, L., Pavlica, P., Menchi, I., De Matteis, M. & Canepari, M. Prostatic abscess: diagnosis and treatment. Am. J. Roentgenol. 170, 753–757 (1998).
Faris, G., Metz, Y., Friedman, B., Appel, B. & Stein, A. Prostatic abscess—diagnosis and treatment [Hebrew]. Harefuah 147, 594–596 (2008).
Author information
Authors and Affiliations
Contributions
C. M. Brede researched data for the article. C. M. Brede and D. A. Shoskes contributed to discussions of content and wrote the article. D. A. Shoskes reviewed and edited the article before submission.
Corresponding author
Ethics declarations
Competing interests
D. A. Shoskes declares that he is a consultant for Farr Laboratories.
Rights and permissions
About this article
Cite this article
Brede, C., Shoskes, D. The etiology and management of acute prostatitis. Nat Rev Urol 8, 207–212 (2011). https://doi.org/10.1038/nrurol.2011.22
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2011.22
This article is cited by
-
Treatment of prostatitis with low-intensity extracorporeal shockwave therapy (LI-ESWT)
International Urology and Nephrology (2023)
-
Human microbiome and prostate cancer development: current insights into the prevention and treatment
Frontiers of Medicine (2021)
-
The seminal microbiome in health and disease
Nature Reviews Urology (2019)
-
Akute Infektionen des unteren Urogenitaltrakts
MMW - Fortschritte der Medizin (2019)